NCT01851265View on ClinicalTrials.gov

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 4, 2013

Primary Completion Date

October 18, 2013

Study Completion Date

June 6, 2017

Conditions
Solid Tumours
Interventions
DRUG

Olaparib

400mg olaparib capsule formulation taken 30 minutes after allocated meal. 5-14 days between arms.

OTHER

Dietary Fasted

Allocated breakfast prior to dosing with 400mg olaparib capsules

OTHER

Dietary standard

Allocated breakfast prior to dosing with 400mg olaparib capsules

OTHER

Dietary High Fat

Allocated breakfast prior to dosing with 400mg olaparib capsules

Trial Locations (7)

2610

Research Site, Wilrijk

2650

Research Site, Edegem

3000

Research Site, Leuven

1081 HV

Research Site, Amsterdam

6202 AZ

Research Site, Maastricht

G12 0YN

Research Site, Glasgow

M20 4BX

Research Site, Manchester

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01851265 - D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours | Biotech Hunter | Biotech Hunter